Sales #DIV/0! #DIV/0!

144% 132% 124% 118% 120% 115% 116%

Expenses #DIV/0! #DIV/0! 142% 138% 118% 120% 115% 116% 118%
Operating Profit #DIV/0! #DIV/0! 153% 113% 142% 112% 134% 113% 111%
Net profit #DIV/0! #DIV/0! 154% 123% 144% 120% 138% 117% 110%
DR LAL PATHLABS LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Trailing Best Case Worst Case 1.01
Sales - - 237.27 342.21 451.66 557.95 659.59 791.32 912.38 1,056.92 1,139.30 1,236.80 1,237.41 #DIV/0!
Expenses - - 180.55 255.58 353.74 418.86 503.64 581.59 674.58 792.84 856.90 917.98 930.69 #DIV/0!
Operating Profit - - 56.72 86.63 97.92 139.09 155.95 209.73 237.80 264.08 282.40 318.81 306.72 #DIV/0!
Operating Profit % #DIV/0! #DIV/0! 23.91 25.31 21.68 24.93 23.64 26.50 26.06 24.99 24.79 25.78 24.79 #DIV/0!
Other Income - - 2.39 2.17 3.10 7.54 12.36 19.77 27.25 31.13 36.30 - - #DIV/0!
Other Income % #DIV/0! #DIV/0! 4% 3% 3% 5% 8% 9% 11% 12% 13% 0% 0% #DIV/0!
EBIDT - - 59.11 88.80 101.02 146.63 168.31 229.50 265.05 295.21 318.70 318.81 306.72 #DIV/0!
EBIDT % #DIV/0! #DIV/0! 24.91 25.95 22.37 26.28 25.52 29.00 29.05 27.93 27.97 25.78 24.79 #DIV/0!
Depreciation - - 13.60 19.83 20.40 27.23 28.19 28.28 27.54 33.06 36.90 36.90 36.90 #DIV/0!
Interest - - 0.78 2.53 0.44 0.20 0.40 0.50 0.70 0.84 0.80 0.80 0.80 #DIV/0!
Interest Coverage Ratio #DIV/0! #DIV/0! 72.72 34.24 222.55 695.45 389.88 419.46 339.71 314.38 353.00 398.51 383.40 #DIV/0!
Profit before tax - - 44.73 66.43 80.20 119.21 139.72 200.72 236.82 261.32 281.00 281.11 269.02 #DIV/0!
Profit before tax % #DIV/0! #DIV/0! 18.85 19.41 17.76 21.37 21.18 25.37 25.96 24.72 24.66 22.73 21.74 #DIV/0!
Tax - - 15.18 21.26 24.55 38.94 43.28 67.48 81.23 89.53 97.40 35% 35% #DIV/0!
Tax % #DIV/0! #DIV/0! 33.94 32.00 30.61 32.67 30.98 33.62 34.30 34.26 34.66 0.12 0.13 #DIV/0!
Net profit - - 29.12 44.71 55.13 79.59 95.68 132.19 154.59 170.77 182.50 183.67 175.77 #DIV/0!
Net profit % #DIV/0! #DIV/0! 12.27 13.07 12.21 14.26 14.51 16.70 16.94 16.16 16.02 14.85 14.20 #DIV/0!
EPS - - 85.86 133.28 164.33 14.83 17.51 15.99 18.61 20.49 21.90 22.04 21.09 #DIV/0!
Price to earning 61.64 51.73 41.98 47.53 50.72 47.53 #VALUE!
Price - - - - - - - 985.50 962.73 860.18 1,040.70 1,117.73 1,002.33 #DIV/0!
#DIV/0!
RATIOS: #DIV/0!
Dividend Payout 0.00% 0.00% 19.13% 19.26% 9.40% 7.17% 8.76% 15.33% 16.12% 21.96% #DIV/0!
OPM 0.00% 0.00% 23.91% 25.31% 21.68% 24.93% 23.64% 26.50% 26.06% 24.99% 24.79% #DIV/0!

Price/Sales #DIV/0!
TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST
Sales Growth 23.79% 18.53% 17.02% 15.84% 17.02% 15.84%
OPM 24.91% 24.96% 25.30% 25.78% 24.79% 25.78% 24.79%
Price to Earning 50.72 50.72 50.72 50.72 47.53 50.72 47.53
Sales 118% 79% 106% 113% 112% 94% 102%
Expenses 112% 88% 106% 108% 109% 103% 98%
Operating Profit 132% 59% 106% 132% 119% 73% 113%
Net profit 133% 58% 102% 141% 115% 71% 111%
DR LAL PATHLABS LTD SCREENER.IN

Narration Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18
Sales 222.80 262.20 207.50 219.90 249.30 278.10 262.70 266.80 292.30 317.50
Expenses 162.30 182.20 160.40 170.10 183.80 200.20 206.10 202.80 217.30 230.70
Operating Profit 60.50 80.00 47.10 49.80 65.50 77.90 56.60 64.00 75.00 86.80
Other Income 6.40 6.90 7.40 6.80 7.50 7.70 7.10 8.90 9.40 10.90
Depreciation 6.30 6.50 7.00 7.70 6.90 7.50 8.00 10.70 8.80 9.40
Interest 0.10 0.10 0.30 0.20 0.10 0.30 0.20 0.20 0.20 0.20
Profit before tax 60.50 80.30 47.20 48.70 66.00 77.80 55.50 62.00 75.40 88.10
Tax 20.50 27.30 16.20 17.20 21.60 26.90 19.20 21.80 25.70 30.70
Net profit 40.00 53.00 30.80 31.30 44.10 50.60 36.00 40.10 49.40 57.00

OPM 27% 31% 23% 23% 26% 28% 22% 24% 26% 27%
DR LAL PATHLABS LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Equity Share Capital - - 3.39 3.35 3.36 53.68 54.63 82.68 83.07 83.33
Reserves - - 87.79 110.95 157.03 151.18 259.82 423.94 512.45 707.85
Total Shareholder Funds - - 91.18 114.30 160.39 204.86 314.45 506.62 595.52 791.18
Borrowings - - 19.64 0.01 0.38 0.87 - - - -
Other Liabilities - - 59.32 63.29 108.92 146.58 161.87 119.69 96.28 129.97
Total - - 170.14 177.60 269.69 352.31 476.32 626.31 691.80 921.15
Debt/Equity Ratio #DIV/0! #DIV/0! 0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio #DIV/0! #DIV/0! 0.67 0.54 0.46 0.97 1.19 2.18 3.11 2.94
Net Block - - 112.04 108.29 126.55 139.83 150.08 165.64 152.43 210.82
Capital Work in Progress - - 0.32 6.22 0.52 0.17 0.95 4.09 17.51 9.56
Investments - - 1.01 4.77 54.77 8.59 37.92 64.32 106.08 144.80
Other Assets - - 56.77 58.32 87.85 203.72 287.37 392.26 415.78 555.97
Total - - 170.14 177.60 269.69 352.31 476.32 626.31 691.80 921.15

Working Capital - - -2.55 -4.97 -21.07 57.14 125.50 272.57 319.50 426.00
Debtors - - 9.69 14.33 19.79 25.16 30.96 36.31 41.80 41.16
Inventory - - 7.75 6.23 8.63 11.66 14.28 14.52 17.91 27.34

Debtor Days - - 14.91 15.28 15.99 16.46 17.13 16.75 16.72 14.21
Inventory Turnover - - 30.62 54.93 52.34 47.85 46.19 54.50 50.94 38.66

Return on Equity 32% 39% 34% 39% 30% 26% 26% 22%
Return on Capital Emp 26% 44% 50% 37% 31% 26% 27% 22%
DR LAL PATHLABS LTD SCREENER.IN

Narration Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity - - 41.78 68.13 88.13 97.96 121.77 158.54 171.31 197.07 944.69 #DIV/0!
Cash from Investing Activity - - -18.59 -26.26 -64.01 -89.30 -113.45 -163.49 -137.11 -172.28 -784.49 #DIV/0!
Cash from Financing Activity - - -22.15 -38.34 -14.79 -10.20 -0.80 0.36 -32.26 12.51 -105.67 #DIV/0!
Net Cash Flow - - 1.04 3.53 9.33 -1.54 7.52 -4.59 1.94 37.30 54.53

Net profit 0 0 29.12 44.71 55.13 79.59 95.68 132.19 154.59 170.77 761.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.

dalal-street.in
COMPANY NAME DR LAL PATHLABS LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10

META
Number of shares 8.33
Face Value 10
Current Price 1040.7
Market Capitalization 8673.36

PROFIT & LOSS

Report Date Mar-09 Mar-10 Mar-11 Mar-12
Sales 237.27 342.21
Raw Material Cost
Change in Inventory
Power and Fuel 4.27 5.28
Other Mfr. Exp 72.35 93.93
Employee Cost 37.79 53.77
Selling and admin 60.84 94.34
Other Expenses 5.30 8.26
Other Income 2.39 2.17
Depreciation 13.60 19.83
Interest 0.78 2.53
Profit before tax 44.73 66.43
Tax 15.18 21.26
Net profit 29.12 44.71
Dividend Amount 5.57 8.61

Quarters
Report Date Jun-16 Sep-16 Dec-16 Mar-17
Sales 222.80 262.20 207.50 219.90
Expenses 162.30 182.20 160.40 170.10
Other Income 6.40 6.90 7.40 6.80
Depreciation 6.30 6.50 7.00 7.70
Interest 0.10 0.10 0.30 0.20
Profit before tax 60.50 80.30 47.20 48.70
Tax 20.50 27.30 16.20 17.20
Net profit 40.00 53.00 30.80 31.30
Operating Profit 60.5 80 47.1 49.8
BALANCE SHEET
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Equity Share Capital 3.39 3.35
Reserves 87.79 110.95
Borrowings 19.64 0.01
Other Liabilities 59.32 63.29
Total 170.14 177.60
Net Block 112.04 108.29
Capital Work in Progress 0.32 6.22
Investments 1.01 4.77
Other Assets 56.77 58.32
Total 170.14 177.60
Receivables 9.69 14.33
Inventory 7.75 6.23
Cash & Bank 22.46 13.44
No. of Equity Shares 339170 335448
New Bonus Shares
Face value 100 100

CASH FLOW:
Report Date Mar-09 Mar-10 Mar-11 Mar-12
Cash from Operating Activity 41.78 68.13
Cash from Investing Activity -18.59 -26.26
Cash from Financing Activity -22.15 -38.34
Net Cash Flow 1.04 3.53

PRICE:

DERIVED:
Adjusted Equity Shares in Cr - - 0.34 0.34
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18

451.66 557.95 659.59 791.32 912.38 1,056.92
139.16 172.92 197.08 226.03

7.53 9.66 11.26 12.78 13.58 15.32

121.68 149.94 40.04 17.54 120.24 149.85
93.80 101.57 134.39 136.83 152.01 180.75
119.75 143.22 162.72 219.79 164.73 190.49
10.98 14.47 16.07 21.73 26.94 30.40
3.10 7.54 12.36 19.77 27.25 31.13
20.40 27.23 28.19 28.28 27.54 33.06
0.44 0.20 0.40 0.50 0.70 0.84
80.20 119.21 139.72 200.72 236.82 261.32
24.55 38.94 43.28 67.48 81.23 89.53
55.13 79.59 95.68 132.19 154.59 170.77
5.18 5.71 8.38 20.26 24.92 37.50

Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18

249.30 278.10 262.70 266.80 292.30 317.50
183.80 200.20 206.10 202.80 217.30 230.70
7.50 7.70 7.10 8.90 9.40 10.90
6.90 7.50 8.00 10.70 8.80 9.40
0.10 0.30 0.20 0.20 0.20 0.20
66.00 77.80 55.50 62.00 75.40 88.10
21.60 26.90 19.20 21.80 25.70 30.70
44.10 50.60 36.00 40.10 49.40 57.00
65.5 77.9 56.6 64 75 86.8
Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18
3.36 53.68 54.63 82.68 83.07 83.33
157.03 151.18 259.82 423.94 512.45 707.85
0.38 0.87
108.92 146.58 161.87 119.69 96.28 129.97
269.69 352.31 476.32 626.31 691.80 921.15
126.55 139.83 150.08 165.64 152.43 210.82
0.52 0.17 0.95 4.09 17.51 9.56
54.77 8.59 37.92 64.32 106.08 144.8
87.85 203.72 287.37 392.26 415.78 555.97
269.69 352.31 476.32 626.31 691.80 921.15
19.79 25.16 30.96 36.31 41.80 41.16
8.63 11.66 14.28 14.52 17.91 27.34
21.46 105.67 148.19 209.95 239.52 313.51
335490 5367840 54629520 82676997 83066184 83332744

100 100 10 10 10 10

Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18

88.13 97.96 121.77 158.54 171.31 197.07
-64.01 -89.30 -113.45 -163.49 -137.11 -172.28
-14.79 -10.20 -0.80 0.36 -32.26 12.51
9.33 -1.54 7.52 -4.59 1.94 37.30

985.50 962.73 860.18

0.34 5.37 5.46 8.27 8.31 8.33